SANUWAVE closes $12M private placement, appoints Morgan Frank as Board Chairman

SANUWAVE Health, Inc.

Issued $16.1M convertible notes (new capital $12.2M) and warrants for 806M shares at $0.04–$0.067; net proceeds $14.4M.
Settled $4.2M debt with Leviston Resources for $3.2M cash + 16.7M shares.
Morgan Frank (Manchester Management) appointed Board Chairman, effective Aug 5, 2022; Kevin Richardson remains CEO.
Proceeds to expand production capacity, pay off existing debt, and initiate NASDAQ up-listing process.

item 1.01 item 1.02 item 2.03 item 3.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Morgan Frank

Chair of the Board

SNWV · SANUWAVE Health, Inc.

Effective: 2022-08-05
Filed: August 8, 2022, 7:59 PM ET

On August 5, 2022, Morgan Frank was appointed to the Board to serve as Chair, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Morgan Frank was appointed as Chair of the Board at SANUWAVE Health, Inc..

Action: appointed
Role: Chair of the Board

Exact text from the filing

On August 5, 2022, Morgan Frank was appointed to the Board to serve as Chair, effective immediately.

View on SEC.gov

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-22-028767

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.